Enanta Pharmaceuticals Stock Forward View - Accumulation Distribution

ENTA Stock  USD 12.90  0.25  1.98%   
Enanta Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Enanta Pharmaceuticals stock prices and determine the direction of Enanta Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Enanta Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Enanta Pharmaceuticals' share price is approaching 48 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enanta Pharmaceuticals, making its price go up or down.

Momentum 48

 Impartial

 
Oversold
 
Overbought
The successful prediction of Enanta Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Enanta Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Enanta Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
(0.66)
EPS Estimate Next Quarter
(1.02)
EPS Estimate Current Year
(3.09)
EPS Estimate Next Year
(2.73)
Wall Street Target Price
19.125
Using Enanta Pharmaceuticals hype-based prediction, you can estimate the value of Enanta Pharmaceuticals from the perspective of Enanta Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enanta Pharmaceuticals using Enanta Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enanta using crowd psychology based on the activity and movement of Enanta Pharmaceuticals' stock price.

Enanta Pharmaceuticals Implied Volatility

    
  1.08  
Enanta Pharmaceuticals' implied volatility exposes the market's sentiment of Enanta Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enanta Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enanta Pharmaceuticals stock will not fluctuate a lot when Enanta Pharmaceuticals' options are near their expiration.

Enanta Pharmaceuticals after-hype prediction price

    
  USD 12.9  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.

Prediction based on Rule 16 of the current Enanta contract

Based on the Rule 16, the options market is currently suggesting that Enanta Pharmaceuticals will have an average daily up or down price movement of about 0.0675% per day over the life of the 2026-04-17 option contract. With Enanta Pharmaceuticals trading at USD 12.9, that is roughly USD 0.008708 . If you think that the market is fully incorporating Enanta Pharmaceuticals' daily price movement you should consider acquiring Enanta Pharmaceuticals options at the current volatility level of 1.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-04-17 Enanta Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Enanta Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Enanta Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Enanta Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Enanta Pharmaceuticals' open interest, investors have to compare it to Enanta Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Enanta Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Enanta. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Enanta Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Enanta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enanta using various technical indicators. When you analyze Enanta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Enanta Pharmaceuticals has current Accumulation Distribution of 5192.17. The accumulation distribution (A/D) indicator shows the degree to which Enanta Pharmaceuticals is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Enanta Pharmaceuticals to determine if accumulation or reduction is taking place in the market. This value is adjusted by Enanta Pharmaceuticals trading volume to give more weight to distributions with higher volume over lower volume.
Check Enanta Pharmaceuticals VolatilityBacktest Enanta PharmaceuticalsInformation Ratio  

Enanta Pharmaceuticals Trading Date Momentum

On January 29 2026 Enanta Pharmaceuticals was traded for  12.90  at the closing time. The top price for the day was 13.03  and the lowest listed price was  12.53 . The trading volume for the day was 135.3 K. The trading history from January 29, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.79% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Enanta Pharmaceuticals to competition

Other Forecasting Options for Enanta Pharmaceuticals

For every potential investor in Enanta, whether a beginner or expert, Enanta Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enanta Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enanta. Basic forecasting techniques help filter out the noise by identifying Enanta Pharmaceuticals' price trends.

Enanta Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enanta Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Enanta Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Enanta Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Enanta Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Enanta Pharmaceuticals stock market strength indicators, traders can identify Enanta Pharmaceuticals entry and exit signals to maximize returns.

Enanta Pharmaceuticals Risk Indicators

The analysis of Enanta Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enanta Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enanta stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Enanta Pharmaceuticals

The number of cover stories for Enanta Pharmaceuticals depends on current market conditions and Enanta Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enanta Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enanta Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Enanta Pharmaceuticals Short Properties

Enanta Pharmaceuticals' future price predictability will typically decrease when Enanta Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enanta Pharmaceuticals often depends not only on the future outlook of the potential Enanta Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enanta Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding21.3 M
Cash And Short Term Investments188.9 M
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Enanta Pharmaceuticals to cross-verify your projections.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. Projected growth potential of Enanta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enanta Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.66)
Earnings Share
(3.84)
Revenue Per Share
3.062
Quarterly Revenue Growth
0.035
Return On Assets
(0.16)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Enanta Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enanta Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Enanta Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.